Ablation Compared to Drug Therapy for Recurrent Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy; Results from a Multicenter Study

The comparative efficacy of antiarrhythmic drug therapy (AAD) versus ventricular tachycardia (VT) ablation in arrhythmogenic right ventricular cardiomyopathy (ARVC) is unknown.

Source: Heart Rhythm - October 23, 2018 Category: Cardiology Authors: Saagar Mahida, Jeroen Venlet, Ardan Muammer Saguner, Saurabh Kumar, Samuel H. Baldinger, Amir AbdelWahab, Usha B. Tedrow, Silvia Castelletti, Antonis Pantazis, Roy M. John, William J. McKenna, Pier D. Lambiase, Firat Duru, John L. Sapp, Katja Zeppenfeld, Source Type: research